FAM29A Antibody
Novus Biologicals, part of Bio-Techne | Catalog # NBP2-87417
Key Product Details
Species Reactivity
Validated:
Human
Applications
Western Blot
Label
Unconjugated
Antibody Source
Polyclonal Rabbit
Concentration
0.5 mg/ml
Product Summary for FAM29A Antibody
Immunogen
The immunogen is a synthetic peptide directed towards the middle region of human FAM29A. Peptide sequence: DFNLQALRSRYEALKKSLSKKREESYLSNSQTPERHKPELSPTPQNVQTD The peptide sequence for this immunogen was taken from within the described region.
Clonality
Polyclonal
Host
Rabbit
Scientific Data Images for FAM29A Antibody
![Western Blot: FAM29A Antibody [NBP2-87417]](https://resources.bio-techne.com/images/products/FAM29A-Antibody-Western-Blot-NBP2-87417-img0001.jpg "Western Blot: FAM29A Antibody [NBP2-87417]")
Western Blot: FAM29A Antibody [NBP2-87417]
Western Blot: FAM29A Antibody [NBP2-87417] - WB Suggested Anti-FAM29A Antibody Titration: 0.2-1 ug/ml. ELISA Titer: 1:312500. Positive Control: Human MuscleApplications for FAM29A Antibody
Application
Recommended Usage
Western Blot
1.0 ug/ml
Please Note: Optimal dilutions of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Affinity purified
Formulation
PBS, 2% Sucrose
Preservative
0.09% Sodium Azide
Concentration
0.5 mg/ml
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Background: FAM29A
Alternate Names
dgt6, dim gamma-tubulin homolog, FAM29AMGC102696, family with sequence similarity 29, member A, FLJ20060, HAUS augmin-like complex subunit 6, HAUS augmin-like complex, subunit 6, KIAA1574, MGC138798, MGC138799
Gene Symbol
HAUS6
Additional FAM29A Products
Product Specific Notices for FAM29A Antibody
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...